Gene · 6196
Papers2,567
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,567
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progranulin Oncogenic Network in Solid Tumors. | Cancers (Basel) | 2023 | 36980592 | PubTator, text mining | PubMed |
| PRL-1/2 phosphatases control TRPM7 magnesium-dependent function to regulate cellular bioenergetics. | Proc Natl Acad Sci U S A | 2023 | 36972446 | PubTator, text mining | PubMed |
| Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis. | Front Oncol | 2023 | 36969076 | PubTator, text mining | PubMed |
| Mediation effects of DNA methylation and hydroxymethylation on birth outcomes after prenatal per- and polyfluoroalkyl substances (PFAS) exposure in the Michigan mother-infant Pairs cohort. | Clin Epigenetics | 2023 | 36964604 | PubTator, text mining | PubMed |
| Hormonal regulation of metabolism-recent lessons learned from insulin and estrogen. | Clin Sci (Lond) | 2023 | 36942499 | PubTator, text mining | PubMed |
| Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model. | Leukemia | 2023 | 36928007 | PubTator, text mining | PubMed |
| tRNA Modifications and Modifying Enzymes in Disease, the Potential Therapeutic Targets. | Int J Biol Sci | 2023 | 36923941 | PubTator, text mining | PubMed |
| 3D geometry orchestrates the transcriptional landscape of metastatic neuroblastoma cells in a multicellular in vitro bone model. | Mater Today Bio | 2023 | 36910273 | PubTator, text mining | PubMed |
| Transcriptomic profiling and differential analysis reveal the renal toxicity mechanisms of mice under cantharidin exposure. | Toxicol Appl Pharmacol | 2023 | 36907384 | PubTator, text mining | PubMed |
| Phosphoinositide 3-Kinase (PI3K) Inhibitors and Breast Cancer: An Overview of Current Achievements. | Cancers (Basel) | 2023 | 36900211 | PubTator, text mining | PubMed |
| RSK inhibitors as potential anticancer agents: Discovery, optimization, and challenges. | Eur J Med Chem | 2023 | 36898330 | PubTator, text mining | PubMed |
| P90 ribosomal S6 kinases: A bona fide target for novel targeted anticancer therapies? | Biochem Pharmacol | 2023 | 36889445 | PubTator, text mining | PubMed |
| Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4Leu317fsX3 mutation causing WHIM syndrome. | JCI Insight | 2023 | 36883568 | PubTator, text mining | PubMed |
| mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer. | JCI Insight | 2023 | 36883564 | PubTator, text mining | PubMed |
| The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment. | Front Immunol | 2023 | 36875093 | PubTator, text mining | PubMed |
| Role of Circulating Exosomes in Cerebrovascular Diseases: A Comprehensive Review. | Curr Neuropharmacol | 2023 | 36847232 | PubTator, text mining | PubMed |
| Ran GTPase and Its Importance in Cellular Signaling and Malignant Phenotype. | Int J Mol Sci | 2023 | 36834476 | PubTator, text mining | PubMed |
| Ultra-Rare Variants Identify Biological Pathways and Candidate Genes in the Pathobiology of Non-Syndromic Cleft Palate Only. | Biomolecules | 2023 | 36830605 | PubTator, text mining | PubMed |
| Using ΔK280 TauRD Folding Reporter Cells to Screen TRKB Agonists as Alzheimer's Disease Treatment Strategy. | Biomolecules | 2023 | 36830589 | PubTator, text mining | PubMed |
| A Comprehensive Review of Mammalian Pigmentation: Paving the Way for Innovative Hair Colour-Changing Cosmetics. | Biology (Basel) | 2023 | 36829566 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6196/papers?page=14